Skip to main content
    S

    STAAR Surgical Company (STAA)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $25.56
    -0.45 (-1.73%)

    Market Cap: $1.32B

    Last updated: Nov 17, 2026 at 4:10 PM ET

    STAAR Surgical Company (STAA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    STAAR Surgical Company (STAA) has a market cap of $1.32B and an enterprise value of $1.19B. Revenue grew 42.36% over the last 12 months from the 12 months before. It holds $133.61M more cash than debt, 10.09% of its market cap.

    Total Valuation

    Enterprise value is 10.09% below the market cap, as cash exceeds debt.

    Market Cap$1.32B
    Enterprise Value$1.19B
    Latest price (Nov 17, 2026)$25.56

    Key Dates

    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.44% in the quarter ended Sep 30, 2026 and grew 1.36% a year over 2 years.

    Shares Outstanding50.54M
    Shares Change (YoY)+1.83%
    Shares Change (QoQ)+0.44%
    Share Count Growth (2Y CAGR)+1.36%

    Valuation Ratios

    Sales and book value multiples are 3.9x and 3.4x. Its year-end P/E ranged from 30.0x to 220.1x from 2018 to 2023.

    P/E Ratio34.6x
    Forward P/E89.1x
    P/S Ratio3.9x
    Forward P/S3.9x
    P/B Ratio3.4x
    P/TBV Ratio3.8x
    P/FCF Ratio72.4x
    P/OCF Ratio61.9x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 90.3x EBITDA and 64.9x free cash flow.

    EV / Sales3.6x
    EV / EBITDA90.3x
    EV / FCF64.9x

    Price Statistics

    The stock is down 2.89% over 52 weeks and trades 10.89% above its 50-day average.

    Beta (1Y)0.39
    52-Week Change-2.89%
    1-Month Change+16.82%
    3-Month Change+3.65%
    6-Month Change-21.60%
    5-Year Change-79.28%
    10-Year Change+190.41%
    Total Return (1Y)-2.89%
    Total Return (3Y CAGR)-9.80%
    Total Return (5Y CAGR)-25.53%
    Return vs SPY (1Y)-11.99%
    Max Drawdown (1Y)-42.77%
    Max Drawdown (3Y)-71.12%
    Sharpe Ratio (1Y)-0.01
    Correlation with SPY (1Y)0.10
    50-Day Average$23.05
    200-Day Average$23.97
    52-Week Range$15.59 to $35.87
    RSI (14 Days)55.4
    Average Volume (20 Days)775.84K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 4.68x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio4.68x
    Quick Ratio4.08x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is 0.14% over the last 12 months, against a 5-year average of -0.10%.

    Return on Equity (ROE)0.14%
    Return on Assets (ROA)0.11%
    ROE (5Y Average)-0.10%
    ROA (5Y Average)0.00%
    ROIC (5Y Average)-24.68%
    Asset Turnover0.70x
    Inventory Turnover1.89x
    Receivables Turnover3.55x
    Cash Conversion Cycle238 days

    Taxes

    Income tax took 90.48% of pretax income over the last 12 months.

    Income Tax (TTM)$5.04M
    Effective Tax Rate90.48%

    Scores

    STAA has an Altman Z-Score of 8.11, in the safe zone above 2.99, and a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Altman Z-Score8.11
    Altman Z ZoneSafe
    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $328.27M over the last 12 months.

    Revenue$328.27M
    Revenue Growth (YoY)+42.36%
    Gross Profit$241.46M
    Operating Income$701.00K
    Pretax Income$5.57M
    Net Income$530.00K
    EBITDA$12.82M
    Reported EPS (TTM)$0.74

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 77.53% of the $485.16M in total assets.

    Cash and Equivalents$133.61M
    Total Debt$0
    Net Cash$133.61M
    Net Cash Per Share$2.64
    Working Capital$277.89M
    Shareholder Equity$376.13M
    Book Value Per Share$7.44
    Tangible Book Value$341.28M
    Tangible Book Per Share$6.75
    Total Assets$485.16M
    Total Liabilities$109.03M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $3.55M of capital spending, operating cash flow left $17.85M of free cash flow.

    Operating Cash Flow$21.40M
    Capital Expenditures$3.55M
    Free Cash Flow$17.85M
    FCF Per Share$0.36
    Depreciation and Amortization$11.35M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 0.21%, against a 5-year average of -0.75%.

    Gross Margin73.56%
    Operating Margin0.21%
    Pretax Margin1.70%
    Net Margin0.16%
    EBITDA Margin3.91%
    FCF Margin5.44%
    Gross Margin (5Y Average)77.39%
    Operating Margin (5Y Average)-0.75%
    Net Margin (5Y Average)-1.51%

    Growth

    Revenue fell 5.57% a year over 3 years.

    Revenue Growth (3Y CAGR)-5.57%
    Revenue Growth (5Y CAGR)+7.93%
    Book Value Per Share Growth (2Y CAGR)-5.88%
    Tangible Book Per Share Growth (2Y CAGR)-10.22%

    Revenue and profit by year

    Dividends and Yields

    STAA does not pay a dividend. Its free cash flow yield is 1.38%.

    Earnings Yield2.89%
    FCF Yield1.38%
    Shareholder Yield0.00%

    Peer Position

    Against 8 similar companies, STAA has the 4th highest P/E.

    P/E Ratio34.6x vs 24.2x median
    P/S Ratio3.9x vs 3.0x median
    Revenue Growth (Trailing 4 Quarters, YoY)+42.36% vs +9.06% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 23.74% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+23.74%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About STAA

    What is STAA's market cap?

    STAAR Surgical Company has a market cap of $1.32B. Its enterprise value, which adds debt and subtracts cash, is $1.19B.

    What is STAA's P/E ratio?

    STAAR Surgical Company has a trailing P/E ratio of 34.6x and a forward P/E of 89.1x.

    How many shares of STAA are outstanding?

    STAAR Surgical Company has 50.54M shares outstanding. The count is up 1.83% from a year earlier.

    Does STAA pay a dividend?

    No. STAAR Surgical Company does not pay a dividend.

    How much debt does STAA have?

    STAAR Surgical Company has $0 of total debt and $133.61M of cash and equivalents, a net cash position of $133.61M.